- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 417/10 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 417/10
Total number of patents in this class: 1162
10-year publication summary
|
97
|
93
|
77
|
92
|
101
|
85
|
80
|
55
|
76
|
22
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5909 |
60 |
| Bristol-myers Squibb Company | 5080 |
33 |
| Merck Sharp & Dohme LLC | 3689 |
30 |
| LG Chem, Ltd. | 17205 |
28 |
| F. Hoffmann-La Roche AG | 7958 |
25 |
| Genentech, Inc. | 3742 |
21 |
| Syngenta Participations AG | 4970 |
20 |
| Novartis AG | 11238 |
19 |
| Boehringer Ingelheim International GmbH | 4629 |
17 |
| Janssen Pharmaceutica N.V. | 3839 |
16 |
| Bayer AG | 3045 |
15 |
| Amgen Inc. | 3779 |
15 |
| Omeros Corporation | 286 |
15 |
| Gilead Sciences, Inc. | 1879 |
14 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
12 |
| Merck Sharp & Dohme Corp. | 2247 |
11 |
| Rohm and Haas Electronic Materials Korea Ltd. | 546 |
11 |
| Bayer Pharma AG | 1096 |
10 |
| Vertex Pharmaceuticals Incorporated | 1581 |
10 |
| Astellas Pharma Inc. | 1145 |
10 |
| Other owners | 770 |